文献速递甲状腺疾病

Bethesda系统在儿童甲状腺结节中的应用:一项Meta分析

The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis.
PubMed 文献 · Thyroid · 2021-03-04

该Meta分析纳入17篇文章共3687个儿童甲状腺结节,评估Bethesda系统(TBSRTC)的应用。多数类别的频率和恶性风险(ROM)与成人数据无统计学差异,但儿童组在良性、意义不明的不典型/意义不明的滤泡性病变、滤泡性肿瘤/可疑滤泡性肿瘤及可疑恶性类别的切除率(RR)显著高于成人,提示儿童可能存在过度治疗风险。

要点

  • 儿童甲状腺结节多数TBSRTC类别的频率和ROM与成人无显著差异。
  • 儿童良性及不确定结节的切除率显著高于成人,提示过度治疗风险。
  • 需优先制定儿童最佳治疗指南和风险分层工具以精准选择手术患者。

核心结论

  • TBSRTC是儿童甲状腺结节临床决策的有价值工具。
  • 儿童良性和不确定结节的切除率高于成人,但ROM无统计学差异,提示潜在过度治疗风险。

研究设计与样本

  • Meta分析,检索PubMed和Web of Science,纳入17篇文章共3687个儿童甲状腺结节。
  • 采用随机效应模型计算比例及95%CI,并进行亚组分析和meta回归探索异质性。

主要发现

  • 多数TBSRTC类别的频率和ROM与近期发表的145,066个成人甲状腺结节Meta分析无统计学差异。
  • 儿童组切除率在多数类别显著高于成人:良性23.2% [CI=18.6-27.9] vs. 13.0% [CI=9.5-16.5];AUS/FLUS 62.6% [CI=50.3-74.9] vs. 36.2% [CI=29.9-42.5];FN/SFN 84.3% [CI=75.2-93.4] vs. 60.5% [CI=54.5-66.5];可疑恶性93.8% [CI=90.1-97.6] vs. 69.7% [CI=64.0-75.5]。

临床怎么用

  • 临床可应用TBSRTC评估儿童甲状腺结节,但需注意儿童良性及不确定结节的切除率偏高。
  • 应谨慎决定手术干预,避免过度治疗,并优先开发儿童特异性风险分层工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Little is known about the application of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) in pediatric thyroid nodules. This meta-analysis was aimed to investigate the use of TBSRTC in the pediatric population. Methods: Relevant articles were searched in PubMed and Web of Science. Meta-analysis of proportion and its 95% confidence interval (CI) were computed utilizing the random-effect model. We used subgroup analyses and meta-regression to explore the sources of heterogeneities. Egger's regression test and funnel plot visualization were used to examine publication bias. Results: We included 17 articles comprising of 3687 pediatric thyroid nodules for meta-analyses. TBSRTC outputs including frequency and risk of malignancy (ROM) for the majority of categories were not statistically different from recently published meta-analysis of 145,066 thyroid nodules in adult patients. The resection rate (RR) in the pediatric group was significantly higher in most of the categories compared with published adult data: benign, 23.2% [CI = 18.6-27.9] vs. 13.0% [CI = 9.5-16.5]; atypia of undetermined significance/follicular lesion of undetermined significance, 62.6% [CI = 50.3-74.9] vs. 36.2% [CI = 29.9-42.5]; follicular neoplasm/suspicious for follicular neoplasm, 84.3% [CI = 75.2-93.4] vs. 60.5% [CI = 54.5-66.5]; and suspicious for malignancy, 93.8% [CI = 90.1-97.6] vs. 69.7% [CI = 64.0-75.5]. Conclusion: TBSRTC is a valuable tool to make clinical decisions for pediatric patients with thyroid nodules. Pediatric patients with benign and indeterminate thyroid nodules had a higher RR than adult counterpart, but ROM of these categories in adults and children was not statistically different suggesting a potential risk of overtreatment in pediatric patients. Determining the best treatment guidelines and additional tools for risk stratification must be a top priority to precisely identify the target patient groups for surgical intervention.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Vuong HG, Chung DGB, Ngo LM, et al. The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis. Thyroid. 2021. PMID: 33504264. doi:10.1089/thy.2020.0702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。